Individual nonsteroidal antiinflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation

Epidemiology

Volumn 8, Issue 1, 1997, Pages 18-24

  Gutthann, Susanne Pérez ^a   García Rodríguez, Luis A ^b   Raiford, Drusilla S ^a,c  

^a Ciba Geigy SA   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

age; corticosteroids; drug interaction; drug utilization; gastrointestinal toxicity; medical record linkage; nonsteroidal antiinflammatory agents

Indexed keywords

DIFLUNISAL; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; DOSE RESPONSE; DRUG UTILIZATION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STATISTICAL ANALYSIS; STEROID THERAPY; STOMACH PERFORATION;

EID: 0343472105     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-199701000-00003     Document Type: Article

References (22)

1. García Rodríguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual nonsteroidal anti-inflammatory drugs. Lancet 1994;343:769-772.
2. Henry D, Dobson A, Turner C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 1993;105:1078-1088.
3. Kaufman DW, Kelly JP, Sheehan JE, Laszlo A, Wiholm B-E, Aldredsson L, Koff RS, Shapiro S. Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther 1993;53:485-494.
4. Savage RL, Moller PW, Ballantyne CL, Wells JE. Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy. Arthritis Rheum 1993;36:84-90.
5. García Rodríguez LA, Walker AM, Pérez Gutthann S. Nonsteroidal antiinflammatory drugs and gastrointestinal hospitalizations in Saskatchewan: a cohort study. Epidemiology 1992;3:337-342.
6. Nobili A, Mosconi P, Franzosi MG, Tognoni G. Non-steroidal anti-inflammatory drugs and upper gastrointestinal bleeding, a post-marketing case-control study. Pharmacoepidemiol Drug Safety 1992;1:65-72.
7. Langman MJS, Weil J, Wainwright P, Lawson DH, Rawlins MD, Logan RFA, Murphy M, Vessey MP, Colin-Jones DG. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:1075-1078.
8. Laporte JR, Carné X, Vidal X, Moreno V, Juan J. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Lancet 1991;337:85-89.
9. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991;114:257-263.
10. Strand LM, West R. The health databases in Saskatchewan. In: Strom B, ed. Pharmacoepidemiology. New York: Churchill Livingstone, 1989;189-200.
11. García Rodríguez LA, Pérez Gutthann S, Walker AM, Lueck L. Nonsteroidal anti-inflammatory drugs in acute liver injury. BMJ 1992;305:865-868.
12. Pérez Gutthann S, García Rodríguez LA. The increased risk of hospitalizations for acute liver injury in a population with exposure to multiple drugs. Epidemiology 1993;4:496-501.
13. International Classification of Diseases, Clinical Modifications, 9th ed. Ann Arbor, MI: Commission on Professional and Hospital Activities, 1980.
14. Walker AM. Case-control studies: sampling the source population. In: Walker AM. Observation and Inference: An introduction to the methods of epidemiology. Chestnut Hill, MA: Epidemiology Resources Inc., 1991;75-80.
15. Norusus MJ. SPSS Advanced Statistics User's Guide. Chicago: SPSS, 1990.
16. EGRET, revision 3. Reference Manual. Seattle: Statistics and Epidemiology Research Corporation and Cytel Software Corporation, 1993.
17. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992;3:452-456.
18. Bollini P, García Rodríguez LA, Pérez Gutthann S, Walker AM. The impact of research quality and study design on epidemiologic estimates of the effect of NSAIDs on upper gastrointestinal pathology. Arch Intern Med 1992;152: 1289-1295.
19. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of NSAIDs. Ann Intern Med 1991;115:787-796.
20. Hawkey CJ. Non-steroidal anti-inflammatory drugs and peptic ulcers: facts and figures multiply, but do they add up? BMJ 1990;300:278-284.
21. Bateman DN. NSAIDs: time to re-evaluate gut toxicity (Comment). Lancet 1994;343:1051-1052.
22. Bateman DN, Kennedy JG. NSAIDs and elderly patients (Editorial). BMJ 1995;310:817-818.